Piel, Sarah http://orcid.org/0000-0002-1779-3532
Janowska, Joanna I.
Ward, J. Laurenson
McManus, Meagan J.
Jose, Joshua S.
Starr, Jonathan
Sheldon, Malkah
Clayman, Carly L.
Elmér, Eskil
Hansson, Magnus J.
Jang, David H.
Karlsson, Michael
Ehinger, Johannes K. http://orcid.org/0000-0002-2417-5767
Kilbaugh, Todd J.
Funding for this research was provided by:
This work was supported by the CounterAct Program, National Institute of Neurologic Disorders and Stroke (Kilbaugh; R21 NS103826)
Article History
Received: 11 April 2022
Accepted: 15 November 2022
First Online: 25 November 2022
Competing interests
: S.P., E.E., M.J.H., M.K. and J.K.E. have, or have had, salary from and/or equity interest in Abliva AB. S.P., E.E., M.J.H. and J.K.E. have filed patent applications for the use of succinate prodrugs for treatment of lactic acidosis or drug-induced side-effects due to complex I-related impairment of mitochondrial oxidative phosphorylation (WO/2015/155238; patent applicant: Neurovive Pharmaceutical AB; name of inventors: Eskil Elmér, Magnus J. Hansson, Johannes K. Ehinger, Sarah Piel, Steven Moss; international application number: PCT/EP2015/057615; status: filed). S.P., E.E., M.J.H., M.K. and J.K.E. additionally have filed patent applications for the use of protected carboxylic acid-based metabolites for treatment of mitochondrial disorders (WO/2017/060400; patent applicant: Neurovive Pharmaceutical AB; name of inventors: Eskil Elmér, Magnus J. Hansson, Johannes K. Ehinger, Sarah Piel, Michael Karlsson, Steven Moss; international application number: PCT/EP2016/073955; status: filed) (WO/2017/060418; patent applicant: Neurovive Pharmaceutical AB; name of inventors: Eskil Elmér, Magnus J. Hansson, Johannes K. Ehinger, Sarah Piel, Michael Karlsson, Steven Moss; international application number: PCT/EP2016/073985; status: filed) (WO/2017/060422; patent applicant: Neurovive Pharmaceutical AB; name of inventors: Eskil Elmér, Magnus J. Hansson, Johannes K. Ehinger, Sarah Piel, Michael Karlsson, Steven Moss; international application number: PCT/EP2016/073992; status: filed).